He is a member of numerous national and international scientific societies, such as the European Association for Haematopathology, the European Bone Marrow Working Group (of which he is also President Elect) and the International Council for Standardization in Haematology. He is also an editorial board member of Pathobiology and an official expert in the field of pathology for the Swiss Accreditation Authority. His major interests and diagnostic expertise lie within haematopathology and mediastinal pathology. Alongside intensive tissue-based research activity on the interaction between SARS-CoV-2 and the human body in COVID-19, his research group is currently involved in translational investigations and precision medicine of lymphomas, particularly clonal relationships, the molecular evolution of relapsing lymphomas and deciphering the genetic landscape of marginal zone lymphomas. He has authored or co-authored >370 papers (orcid.org/0000-0002-1100-3819). In the framework of the FTC project, Prof Tzankov leads the execution of autopsies, tissue collection, study design, histopathological examination, immunohistochemical examination, in situ hybridization examination, interpretation of gene expression data and basic statistics.